Three-dimensional scaffold-free microtissues engineered for cardiac repair.

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Cardiovascular Research

Background:

• Cardiovascular diseases, particularly myocardial infarction (MI), are a leading global cause of death.
• The heart's limited regenerative capacity poses challenges for treating MI and subsequent heart failure (HF).
• Current treatments focus on managing damage rather than regenerating cardiac tissue.

Purpose of the Study:

• To review state-of-the-art approaches in engineering scaffold-free cardiac microtissues (SF-CMTs) for myocardial repair.
• To highlight advancements in overcoming clinical translation barriers for cardiac regenerative medicine.

Main Methods:

• Categorization of cardiac regenerative medicine approaches: cell-based, scaffold-based, and scaffold-free.
• Integration of micro/nanoscale technologies and stem cell advancements for tissue engineering.
• Focus on engineering structurally mature and functional SF-CMTs.

Main Results:

• Significant advancements in cardiac regenerative medicine, including SF-CMTs.
• Engineering SF-CMTs enhances cellular organization and electromechanical coupling.
• Micro/nanoscale technologies improve tissue integration and function for MI and HF treatment.

Conclusions:

• Scaffold-free cardiac microtissue engineering presents a promising avenue for myocardial repair.
• Overcoming poor engraftment and weak electromechanical coupling is crucial for clinical success.
• Advanced engineering techniques are key to developing effective treatments for heart disease.